Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02QXT
|
||||
Former ID |
DNC012762
|
||||
Drug Name |
8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H15NO
|
||||
Canonical SMILES |
COC1=CC2=C(C=C1)C3=C(CCNC3)C=C2
|
||||
InChI |
1S/C14H15NO/c1-16-12-4-5-13-11(8-12)3-2-10-6-7-15-9-14(10)13/h2-5,8,15H,6-7,9H2,1H3
|
||||
InChIKey |
LTVUTAZPBISUIF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [1] | |
Alpha-2A adrenergic receptor | Target Info | Inhibitor | [1] | ||
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [1] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
Neuroactive ligand-receptor interactionhsa04022:cGMP-PKG signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway | |||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Reactome | Adrenoceptors | ||||
Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
Adrenaline,noradrenaline inhibits insulin secretion | |||||
G alpha (i) signalling events | |||||
G alpha (z) signalling events | |||||
Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
Platelet Aggregation (Plug Formation) | |||||
Integration of energy metabolism | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP58:Monoamine GPCRs | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | J Med Chem. 1997 Dec 5;40(25):3997-4005.Examination of the role of the acidic hydrogen in imparting selectivity of 7-(aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) toward inhibition of phenylethanolamine N-methyltransferase vs the alpha 2-adrenoceptor. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.